Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136341 · ClinicalTrials.gov registry record · Phase 4
A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor
A Phase 4 study of Tremor, Limb, sponsored by David M. Simpson.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT03136341 is a Phase 4 study of Tremor, Limb that is actively recruiting participants, run by David M. Simpson. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03136341, a Phase 4 study of Tremor, Limb, is actively recruiting participants, sponsored by David M. Simpson.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Task-dependent upper limb tremor is a disorder that frequently impairs patients' function and quality of life. Few studies exist that quantify the improvements in motor performance and disability with botulinum toxin (injections). The study team aims to perform an exploratory pilot trial using toxin Type A (Dysport) in 25 patients with task-dependent upper limb tremor, to refine quantitative measures of performance using blinded video analysis, demonstrate efficacy and tolerability of injections, and provide power calculations for a potential future multi-centered double blinded clinical trial.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Abobotulinum toxin A
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2022-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03136341
The ClinicalTrials.gov registry entry for NCT03136341 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is David M. Simpson, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tremor, Limb appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03136341 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03136341 about?
NCT03136341 is a clinical study titled "A Cross Over Pilot Study of Abobotulinum Toxin A (Dysport) as a Treatment for Task-dependent Upper Limb Tremor". Task-dependent upper limb tremor is a disorder that frequently impairs patients' function and quality of life. Few studies exist that quantify the improvements in motor performance and disability with botulinum toxin (injections). The study team aims to perform an exploratory pilot trial using toxin...
What is the current status of trial NCT03136341?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2018-12-04. Estimated completion is 2022-12.
What conditions does trial NCT03136341 study?
This clinical trial studies the following conditions: Tremor, Limb.
What interventions are being tested in trial NCT03136341?
The interventions under investigation include: Placebo (OTHER), Abobotulinum toxin A (DRUG).
Who is sponsoring clinical trial NCT03136341?
This trial is sponsored by David M. Simpson, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136341 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tremor, Limb
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.